Study of RHB-204 for the Treatment of Pulmonary Mycobacterium avium Complex (MAC) Disease
Status: Ongoing
Details
Study of RHB-204 for the Treatment of Pulmonary Mycobacterium avium Complex (MAC) Disease in Adults with Nodular Bronchiectasis (CleaR-MAC Trial)
Sponsor: Redhill Biopharma
NCT04616924
